News

DayOne Tech supports three medtech startups

DayOne, the healthcare innovation initiative from Basel Area Business & Innovation, has started its medtech accelerator in the canton of Jura with three startups. CNS Therapy, Moonlight AI, and CryoThermo 4.0 will receive access to coaching, the ecosystem, office space, and funds over twelve months.

CNS Therapy, Moonlight AI and CryoThermo 4.0 are funded by the Medtech Accelerator in the Canton of Jura of the Healthcare Innovation Initiative of Basel Area Business & Innovation.
CNS Therapy, Moonlight AI and CryoThermo 4.0 are funded by the Medtech Accelerator in the Canton of Jura of the Healthcare Innovation Initiative of Basel Area Business & Innovation. Generic image: Gerd Altmann/Pixabay

Three medtech startups began their year-long journey through DayOne Tech’s acceleration program in the canton of Jura on August 17. According to a press release, they are CNS TherapyMoonlight AI, and CryoThermo 4.0. They will gain access to coaching, the ecosystem, office space, and funds. The healthcare innovation initiative from Basel Area Business & Innovation, a location and innovation promotion agency, brings together professionals and specialists from various disciplines and companies in the Basel Area to strengthen the healthcare ecosystem and make it more sustainable.

CNS Therapy from Zug has developed a treatment for chronic pain without medication, surgery, or implants. Its systolic extinction therapy, for example, using neuromodulation and behavioral therapy has been proven effective in randomized studies. It is an innovative, interactive behavioral therapy combined with a patented medical device. 

Moonlight AI with headquarters at the Switzerland Innovation Park Basel Area – Jura in Courroux in the Swiss canton of Jura develops artificial intelligence models to predict genomic biomarkers that are therapeutically relevant. It uses scans of stained hematology or pathology slides to do so. The startup aims to use these to democratize access to genomic information for therapeutic decisions. 

CryoThermo 4.0 is developing a new generation of patented medical thermal compresses “thanks to a technological and therapeutic paradigm shift”. The startup also plans to manufacture and market these. The aim is to become the global leader in this area.

Handbook for Investors

Our Handbook for Investors provides valuable information about technologies and production costs, taxes and financing, as well as the legal system and infrastructure in Switzerland. Browse through the complete handbook online or download the chapters most relevant to you.

Partager

Programme officiel